Frank Clyburn compensation by year
Merck Summary Compensation Table · the one fiscal year held| Component | FY2021 |
|---|---|
| Salary | $960,343 |
| Bonus | $0 |
| Stock awards | $5,956,031 |
| Option awards | $1,290,003 |
| Non-equity incentive | $1,443,506 |
| Pension and deferred compensation | $187,604 |
| All other | $83,584 |
| Total | $9,921,071 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Merck & Co., Inc. DEF 14A filed April 4, 2022, accession 0001193125-22-095134, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Merck & Co., Inc. filed document, accession 0001193125-22-095134. Every figure is read from that document and cited to the page and table it appears in. Filed April 4, 2022.
Merck’s named executive officers, FY2021
as the company reported each| Named executive officer | Role | FY2021 total |
|---|---|---|
| Kenneth Frazier | Executive Chairman and Former Chief Executive Officer | $15,196,920 |
| Robert Davis | Chief Executive Officer, President and Former Chief Financial Officer | $13,722,121 |
| Frank Clyburn · this page | Former Executive Vice President and President, Human Health | $9,921,071 |
| Richard DeLuca | Executive Vice President and President, Merck Animal Health | $6,841,000 |
| Dean Li | Executive Vice President and President, Merck Research Laboratories | $5,480,919 |
| Caroline Litchfield | Executive Vice President and Chief Financial Officer | $4,221,454 |
The full Merck compensation record
free company briefThis page is one person within Merck's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the Merck proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Merck's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.